Archives of Virology

, Volume 71, Issue 4, pp 303–310 | Cite as

Neutralising antibody in mice with primary and recurrent herpes simplex virus infection

  • J. M. Darville
  • W. A. Blyth
Original Papers

Summary

Neutralising antibody was studied in mice infected in the ear with herpes simplex virus type 1. Antibody was detected six days after infection and after one month it had reached titres which subsequently varied little. Geometric group mean titres were doubled by reinoculation of virus whereas recurrent disease induced by trauma did not change them (although titres did change in some individual animals).

Mean titres in mice which had had unequivocal signs of primary disease were twice as high as in those which had not, and the frequency of recurrent disease in response to trauma in the former animals was greater than in the latter. A reduction in the frequency of induced recurrent disease was seen if the application of trauma was delayed for some time after the establishment of latency.

Hyperimmunisation increased mean titres tenfold. If given soon after primary infection it reduced the frequency of induced recurrent disease but if its administration was delayed then the frequency was increased.

Keywords

Infectious Disease Virus Infection Herpes Simplex Recurrent Disease Virus Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blyth, W. A., Hill, T. J., Field, H. J., Harbour, D. A.: Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J. gen. Virol.33, 547–550 (1976).Google Scholar
  2. 2.
    Blyth, W. A., Harbour, D. A., Hill, T. J.: Effect of immuno suppression on recurrent herpes simplex in mice. Infect. Immun.29, 902–907 (1980).Google Scholar
  3. 3.
    Buddingh, G. H., Schrumm, D. I., Lanier, J. C., Guidry, D. J.: Studies on the natural history of herpes simplex infection. Pediatrics (Springfield)11, 595–610 (1953).Google Scholar
  4. 4.
    Burns, W. H.: Immune responses to herpesvirus infections. In:Mandel, T. E., Cheers, C., Hosking, C. S., McKenzie, I. F. C., Nossal, G. J. V. (eds.), Progress in Immunology, Vol. 3 (Proceedings of the Third International Congress of Immunology, Sydney 1977), 472–479. Amsterdam: North-Holland 1977.Google Scholar
  5. 5.
    Daniels, C. A., Le Goff, S. G., Notkins, A. L.: Shedding of infectious virusantibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet2, 524–528 (1976).Google Scholar
  6. 6.
    Fujimiya, Y., Rouse, B. T., Babiuk, L. A.: Human neutrophil-mediated destruction of antibody sensitized herpes simplex virus type 1 infected cells. Can. J. Microbiol.24, 182–186 (1978).Google Scholar
  7. 7.
    Fujimiya, Y., Babiuk, L. A., Rouse, B. T.: Direct lymphocytotoxicity against herpes simplex virus infected cells. Can. J. Microbiol.24, 1076–1081 (1978).Google Scholar
  8. 8.
    Harbour, D. A., Hill, T. J., Blyth, W. A.: Acute and recurrent herpes simplex in several strains of mice. J. gen. Virol.55, 31–40 (1981).Google Scholar
  9. 9.
    Hill, T. J., Field, H. J., Blyth, W. A.: Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J. gen. Virol.28, 341–353 (1975).Google Scholar
  10. 10.
    Hill, T. J., Blyth, W. A., Harbour, D. A.: Trauma to the skin causes recurrence of herpes simplex in the mouse. J. gen. Virol.39, 21–28 (1978).Google Scholar
  11. 11.
    Hill, T. J., Blyth, W. A., Harbour, D. A.: Manuscript submitted to Antiviral Research.Google Scholar
  12. 12.
    Juel-Jensen, B. E., Maccallum, F. O.: Herpes Simplex, Varicella and Zoster: Clinical manifestations and treatment, 1st ed., 6–76. London: Heineman 1972.Google Scholar
  13. 13.
    Klein, R. J., Friedman-Kien, A. E., Fondak, A. A., Buimovici-Klein, E.: Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice. Infect. Immun.16, 842–848 (1977).Google Scholar
  14. 14.
    Korsager, B., Spencer, E. S., Mordhorst, C.-H., Andersen, H. K.: Herpesvirus hominis infections in renal transplant patients. Scand. J. Infec. Dis.7, 11 to 19 (1975).Google Scholar
  15. 15.
    Lopez, C., O'Reilly, R. J.: Cell-mediated immune responses in recurrent herpes virus infections. I. Lymphocyte proliferation assay. J. Immun.118, 895–902 (1977).Google Scholar
  16. 16.
    Muller, S. A., Herrmann, E. C., Winkelmann, R. K.: Herpes simplex infections in haematological malignancies. Am. J. Med.52, 102–114 (1972).Google Scholar
  17. 17.
    Nash, A. A., Field, H. J., Quartey-Papafio, R.: Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J. gen. Virol.48, 351–357 (1980).Google Scholar
  18. 18.
    Oppenheim, J. J.: Immunological relevance of antigen and antigen-antibody complex induced lymphocyte transformation. Ann. Allergy27, 305–315 (1969).Google Scholar
  19. 19.
    Pelton, B. K., Duncan, I. B., Denman, A. M.: Herpes simplex virus depresses antibody production by affecting T-cell function. Nature284, 176–177 (1980).Google Scholar
  20. 20.
    Provost, T.: Infections associated with T-cell dysfunction. In:Allen, J. C. (ed.), Infection and the Compromised Host, 49–79. Baltimore: Williams and Wilkins 1976.Google Scholar
  21. 21.
    Reichmann, R. C., Dolin, R., Vincent, M. M., Fauci, A. S.: Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man. Proc. Soc. exp. Biol. Med.155, 571–576 (1977).Google Scholar
  22. 22.
    Sekizawa, T., Openshaw, H., Wohlenberg, C., Notkins, A. L.: Latency of herpes simplex virus in absence of neutralising antibody: model for reactivation. Science210, 1026–1028 (1980).Google Scholar
  23. 23.
    Thong, Y. H., Vincent, M. M., Hensen, S. A., Fuccillo, D. A., Rola-Pleszczynski, M., Bellanti, J. A.: Depressed specific cell-mediated immunity to herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect. Immun.12, 76–80 (1975).Google Scholar
  24. 24.
    Vizoso, A. D.: Latency of herpes simiae (herpes B) in rabbits. Br. J. exp. Path.56, 489–494 (1975).Google Scholar
  25. 25.
    Westmoreland, D.: Herpes simplex virus type-1 and human lymphocytes: virus expression and the response to infection of adult and foetal cells. J. gen. Virol.40, 559–575 (1978).Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • J. M. Darville
    • 1
    • 2
  • W. A. Blyth
    • 1
  1. 1.Department of MicrobiologyUniversity of Bristol Medical SchoolBristolEngland
  2. 2.Department of VirologyBristol Royal InfirmaryBristolEngland

Personalised recommendations